21世纪已经到来，人类将步入知识经济时代，而我国也入世在即，医药企业尤其是国有中小型医药商业企业的生存空间将发生重大变化，直接面对着来自国内大企业和国外企业 (集团 )的双重竞争压力。如何在日益激烈的市场竞争中求得生存和发展，是摆在中小企业面前的重大课题。 　 Since the 21st century has come, humanity will enter the era of knowledge economy, and China will soon enter the WTO. The living space of pharmaceutical companies, especially state-owned small and medium-sized pharmaceutical and commercial enterprises, will undergo major changes, directly facing large domestic companies and foreign companies (groups). ) Double competitive pressure. How to seek survival and development in the increasingly fierce market competition is a major issue facing SMEs.